Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDV-Interferon + Ribavirin in Chronic Hepatitis C
NCT00703872Phase 2Unknown
- Sponsor
- Hepasome Pharmaceuticals
- Start
- May 2008
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of HDV-Interferon in hepatitis C (HCV), sponsored by Hepasome Pharmaceuticals. Status: unknown.
02
Drugs
HDV-Interferon
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00703872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703872.